Henri Duboc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Henri Duboc has a total of 215 co-authors. Here are the top co-authors by number of shared publications:
Lydie Humbert
Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint Antoine, Clinical Metabolomics Department
11 shared publicationsDominique Rainteau
Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint Antoine, Clinical Metabolomics Department
9 shared publications- Harry Sokol
Sorbonne Université, INSERM UMRS-938, Centre de Recherche Saint-Antoine, CRSA, AP-HP, F-75012 Paris, France; Gut, Liver & Microbiome Research (GLIMMER) FHU, Paris, France; Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France; Department of Gastroenterology, Saint Antoine Hospital, APHP, Paris, France
9 shared publications Benoit Coffin
Centre de Recherche sur lʼInflammation, Inserm UMRS 1149, Université Paris Cité, Paris, France
8 shared publications- Benoit Coffin
Department of Gastroenterology AP‐HP Nord Hôpital Louis Mourier Colombes France
6 shared publications - Philippe Seksik
Department of Gastroenterology, CRSA, FHU Gut, Liver & Microbiome Research (GLIMMER), Sorbonne Université, INSERM, APHP, Hôpital Saint-Antoine, Paris, France
6 shared publications
Latest Publications
- Open Access
- 17 April 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2658915
Re-establishing bile acid composition after treatment of recurrent Clostridioides difficile infection with fecal microbiota transplantation compared with oral vancomycin or a 12-strain bacterial mixture
Patients with Clostridioides difficile infection have high colonic levels of primary bile acids, which are potent germinators of Clostridioides difficile. Several studies have suggested that re-establishing a normal bile acid composition is a key factor in fecal microbiota transplantation (FMT) for recurrent C. difficile infection, yet former studies supporting this lacked controls. In a subgroup from a randomized controlled trial, we compared the bile acid composition in patients with recurrent C. difficile infection treated with either FMT, a bacterial mixture, or vancomycin. The fecal bile acid content was analyzed several times before and after treatments. Furthermore, we used 16S rDNA gene sequencing to analyze the presence of some bacterial species involved in bile acid metabolism. Stool donors served as healthy controls. We observed a higher proportion of primary bile acids in patients with recurrent C. difficile infection than in donors, yet a donor-like dominance of secondary bile acids was observed after successful treatment in all groups. The shift seemed to occur earliest in the FMT group, followed by the vancomycin group, and the latest in the bacterial mixture group. In approximately half of the participants, the rise in secondary bile acids was timely associated with the detection of bile acid-transforming bacteria that were absent before treatment. Our findings indicate that FMT re-establishes the bile acid composition faster than vancomycin, reducing the time of susceptibility to recurrences of C. difficile infection. Hence, bacterial mixtures developed as an alternative to donor stool for treating recurrent C. difficile infection might benefit from including bile acid-metabolizing bacteria.
- 17 April 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2658915
Open AccessRe-establishing bile acid composition after treatment of recurrent Clostridioides difficile infection with fecal microbiota transplantation compared with oral vancomycin or a 12-strain bacterial mixture
Patients with Clostridioides difficile infection have high colonic levels of primary bile acids, which are potent germinators of Clostridioides difficile. Several studies have suggested that re-establishing a normal bile acid composition is a key factor in fecal microbiota transplantation (FMT) for recurrent C. difficile infection, yet former studies supporting this lacked controls. In a subgroup from a randomized controlled trial, we compared the bile acid composition in patients with recurrent C. difficile infection treated with either FMT, a bacterial mixture, or vancomycin. The fecal bile acid content was analyzed several times before and after treatments. Furthermore, we used 16S rDNA gene sequencing to analyze the presence of some bacterial species involved in bile acid metabolism. Stool donors served as healthy controls. We observed a higher proportion of primary bile acids in patients with recurrent C. difficile infection than in donors, yet a donor-like dominance of secondary bile acids was observed after successful treatment in all groups. The shift seemed to occur earliest in the FMT group, followed by the vancomycin group, and the latest in the bacterial mixture group. In approximately half of the participants, the rise in secondary bile acids was timely associated with the detection of bile acid-transforming bacteria that were absent before treatment. Our findings indicate that FMT re-establishes the bile acid composition faster than vancomycin, reducing the time of susceptibility to recurrences of C. difficile infection. Hence, bacterial mixtures developed as an alternative to donor stool for treating recurrent C. difficile infection might benefit from including bile acid-metabolizing bacteria.
- Open Access
- 10 October 2025
- Published by Springer Nature in BMC Veterinary Research
- Vol. 21 (1) , 600
Functional dyspepsia: from human to dog, a retrospective study of 29 cases illustrating a complex entity
Functional gastrointestinal disorders, including mostly functional dyspepsia (FD) and irritable bowel syndrome, are highly prevalent in human patients. FD is a complex condition in human gastroenterology and is characterized by abdominal discomfort, epigastric pain or burning, postprandial fullness, or early satiety. To our knowledge, such a syndrome, in the absence of organic, metabolic, or systemic causes, has not been reported in dogs. We aimed to provide a comprehensive description of the presentation of suspected canine functional dyspepsia in a retrospective case series. All records of dogs suspected of having dyspeptic clinical signs were studied. Laboratory data, imaging results and gastroscopic findings unlikely to explain the intensity of clinical signs were mandatory for inclusion. Twenty-nine dogs were retrospectively enrolled. All presented with signs of gastrointestinal discomfort but results from bloodwork, abdominal ultrasonography, endoscopy, and histopathology did not fully account for the severity of the clinical signs observed. FD was found to predominantly affect females (66%) and was most associated with vomiting (97%), abdominal pain (58%), intermittent diarrhoea (52%), pica (52%), compulsive chewing behaviours (48%), and belching or excessive yawning (41%), along with other signs of upper gastrointestinal discomfort. The median duration of clinical signs was 1.5 years, with a median age of onset also at 1.5 years. Various treatments were attempted with varying success, including dietary changes, antacids, prokinetics, and steroids. Follow-up data were available for 21 dogs, of which 76% demonstrated clinical improvement over a median follow-up period of 12 months. Interestingly, anxiety disorder of the owner was commonly reported. Functional dyspepsia is a clinically emerging functional gastrointestinal disorder in dogs, especially in toy and small breed, middle-aged, female dogs, characterized by chronic gastrointestinal discomfort and vomiting in the absence of confirmed organic disease. The clinical picture of intense abdominal crisis with highly involved and anxious owners is out of step with the results of investigations. Overlap with food-responsive enteropathies, immunosuppressant-responsive enteropathies, or gastroduodenal dysmotility disorders is still of concern, potentially triggered by emotional disorders. Canine FD could reflect a gut-brain axis disturbance and should be included in the differential diagnosis of refractory canine upper digestive disorders. Tailored therapeutic approaches, including dietary modifications, antacids, and prokinetic agents, may offer clinical benefit.
- 10 October 2025
- Published by Springer Nature in BMC Veterinary Research
- Vol. 21 (1) , 600
Open AccessFunctional dyspepsia: from human to dog, a retrospective study of 29 cases illustrating a complex entity
Functional gastrointestinal disorders, including mostly functional dyspepsia (FD) and irritable bowel syndrome, are highly prevalent in human patients. FD is a complex condition in human gastroenterology and is characterized by abdominal discomfort, epigastric pain or burning, postprandial fullness, or early satiety. To our knowledge, such a syndrome, in the absence of organic, metabolic, or systemic causes, has not been reported in dogs. We aimed to provide a comprehensive description of the presentation of suspected canine functional dyspepsia in a retrospective case series. All records of dogs suspected of having dyspeptic clinical signs were studied. Laboratory data, imaging results and gastroscopic findings unlikely to explain the intensity of clinical signs were mandatory for inclusion. Twenty-nine dogs were retrospectively enrolled. All presented with signs of gastrointestinal discomfort but results from bloodwork, abdominal ultrasonography, endoscopy, and histopathology did not fully account for the severity of the clinical signs observed. FD was found to predominantly affect females (66%) and was most associated with vomiting (97%), abdominal pain (58%), intermittent diarrhoea (52%), pica (52%), compulsive chewing behaviours (48%), and belching or excessive yawning (41%), along with other signs of upper gastrointestinal discomfort. The median duration of clinical signs was 1.5 years, with a median age of onset also at 1.5 years. Various treatments were attempted with varying success, including dietary changes, antacids, prokinetics, and steroids. Follow-up data were available for 21 dogs, of which 76% demonstrated clinical improvement over a median follow-up period of 12 months. Interestingly, anxiety disorder of the owner was commonly reported. Functional dyspepsia is a clinically emerging functional gastrointestinal disorder in dogs, especially in toy and small breed, middle-aged, female dogs, characterized by chronic gastrointestinal discomfort and vomiting in the absence of confirmed organic disease. The clinical picture of intense abdominal crisis with highly involved and anxious owners is out of step with the results of investigations. Overlap with food-responsive enteropathies, immunosuppressant-responsive enteropathies, or gastroduodenal dysmotility disorders is still of concern, potentially triggered by emotional disorders. Canine FD could reflect a gut-brain axis disturbance and should be included in the differential diagnosis of refractory canine upper digestive disorders. Tailored therapeutic approaches, including dietary modifications, antacids, and prokinetic agents, may offer clinical benefit.
- Open Access
- 25 August 2024
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 23 (4) , A32
Emphysematous Hepatitis Due to Clostridium septicum
- 25 August 2024
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 23 (4) , A32
Open AccessEmphysematous Hepatitis Due to Clostridium septicum
- Open Access
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E584
Profuse diarrhea after percutaneous change of a computed tomography-guided gastrostomy: endoscopic closure of a colocutaneous fistula
A 71-year-old patient was admitted after the accidental dislodgement of a computed tomography (CT)-guided percutaneous gastrostomy, placed 1 year prior. The initial procedure was uneventful and facilitated rapid weight gain. A percutaneous MIC-KEY tube (Avanos, Alpharetta, Georgia, USA) was rapidly placed along the previous route. As soon as nutrition was restarted, “on and off” profuse diarrhea occurred, ceasing as the nutrition was stopped and resuming immediately upon resumption. Opacification of the MIC-KEY tube revealed a fistulous tract between the transverse colon and the skin ([Video 1]). Conservative treatment was decided, involving the endoscopic closure of the residual colocutaneous fistula, achieved by placing an Ovesco clip (Ovesco Endoscopy, Tübingen, Germany) during a colonoscopy [1]. In conclusion, a transcolonic perforation may go unnoticed during the months [2] after a CT-guided percutaneous gastrostomy. Colocutaneous fistulous tract can be safely closed using an Ovesco clip during a colonoscopy [1] [3], to avoid the need for surgery. Endoscopy_UCTN_Code_TTT_1AO_2AK Article published online: 08 July 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E584
Open AccessProfuse diarrhea after percutaneous change of a computed tomography-guided gastrostomy: endoscopic closure of a colocutaneous fistula
A 71-year-old patient was admitted after the accidental dislodgement of a computed tomography (CT)-guided percutaneous gastrostomy, placed 1 year prior. The initial procedure was uneventful and facilitated rapid weight gain. A percutaneous MIC-KEY tube (Avanos, Alpharetta, Georgia, USA) was rapidly placed along the previous route. As soon as nutrition was restarted, “on and off” profuse diarrhea occurred, ceasing as the nutrition was stopped and resuming immediately upon resumption. Opacification of the MIC-KEY tube revealed a fistulous tract between the transverse colon and the skin ([Video 1]). Conservative treatment was decided, involving the endoscopic closure of the residual colocutaneous fistula, achieved by placing an Ovesco clip (Ovesco Endoscopy, Tübingen, Germany) during a colonoscopy [1]. In conclusion, a transcolonic perforation may go unnoticed during the months [2] after a CT-guided percutaneous gastrostomy. Colocutaneous fistulous tract can be safely closed using an Ovesco clip during a colonoscopy [1] [3], to avoid the need for surgery. Endoscopy_UCTN_Code_TTT_1AO_2AK Article published online: 08 July 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 25 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (5) , 1848
No Long-Term Mucosal Lesions in the Esophagus but More Gastric Mucosal Lesions after Sleeve Gastrectomy in Obese Rats
Sleeve gastrectomy (SG) often induces gastroesophageal reflux, with few and discordant long-term data on the risk of Barrett’s esophagus (BE) in operated patients. The aim of this study was to analyze the impact of SG on esogastric mucosa in a rat model at 24 weeks postoperatively, which corresponds to approximately 18 years in humans. After 3 months of a high-fat diet, obese male Wistar rats were subjected to SG (n = 7) or sham surgery (n = 9). Esophageal and gastric bile acid (BA) concentrations were measured at sacrifice, at 24 weeks postoperatively. Esophageal and gastric tissues were analyzed by routine histology. The esophageal mucosa of the SG rats (n = 6) was not significantly different in comparison to that of the sham rats (n = 8), with no esophagitis or BE. However, there was more antral and fundic foveolar hyperplasia in the mucosa of the residual stomach 24 weeks after SG than in the sham group (p < 0.001). Luminal esogastric BA concentrations did not differ between the two groups. In our study, SG induced gastric foveolar hyperplasia but no esophageal lesions at 24 weeks postoperatively in obese rats. Therefore, long-term endoscopic esophageal follow-up that is recommended in humans after SG to detect BE may also be useful for detecting gastric lesions.
- 25 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (5) , 1848
Open AccessNo Long-Term Mucosal Lesions in the Esophagus but More Gastric Mucosal Lesions after Sleeve Gastrectomy in Obese Rats
Sleeve gastrectomy (SG) often induces gastroesophageal reflux, with few and discordant long-term data on the risk of Barrett’s esophagus (BE) in operated patients. The aim of this study was to analyze the impact of SG on esogastric mucosa in a rat model at 24 weeks postoperatively, which corresponds to approximately 18 years in humans. After 3 months of a high-fat diet, obese male Wistar rats were subjected to SG (n = 7) or sham surgery (n = 9). Esophageal and gastric bile acid (BA) concentrations were measured at sacrifice, at 24 weeks postoperatively. Esophageal and gastric tissues were analyzed by routine histology. The esophageal mucosa of the SG rats (n = 6) was not significantly different in comparison to that of the sham rats (n = 8), with no esophagitis or BE. However, there was more antral and fundic foveolar hyperplasia in the mucosa of the residual stomach 24 weeks after SG than in the sham group (p < 0.001). Luminal esogastric BA concentrations did not differ between the two groups. In our study, SG induced gastric foveolar hyperplasia but no esophageal lesions at 24 weeks postoperatively in obese rats. Therefore, long-term endoscopic esophageal follow-up that is recommended in humans after SG to detect BE may also be useful for detecting gastric lesions.
- 26 January 2023
- Published by Elsevier in Journal de Chirurgie Viscérale
- Vol. 160 (4) , 269-277
Approche thoracoscopique comme prise en charge chirurgicale de diverticule épiphrénique de l’œsophage
- 26 January 2023
- Published by Elsevier in Journal de Chirurgie Viscérale
- Vol. 160 (4) , 269-277
Approche thoracoscopique comme prise en charge chirurgicale de diverticule épiphrénique de l’œsophage
- 14 May 2022
- Published by Elsevier in Digestive and Liver Disease
- Vol. 54 (10) , 1350-1357
Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID
- 14 May 2022
- Published by Elsevier in Digestive and Liver Disease
- Vol. 54 (10) , 1350-1357
Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID
- Open Access
- 22 November 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Circulating bile acids concentration is predictive of coronary artery disease in human
Synthetized by the liver and metabolized by the gut microbiota, BA are involved in metabolic liver diseases that are associated with cardiovascular disorders. Animal models of atheroma documented a powerful anti-atherosclerotic effect of bile acids (BA). This prospective study examined whether variations in circulating BA are predictive of coronary artery disease (CAD) in human. Consecutive patients undergoing coronary angiography were enrolled. Circulating and fecal BA were measured by high pressure liquid chromatography and tandem mass spectrometry. Of 406 screened patients, 80 were prospectively included and divided in two groups with (n = 45) and without (n = 35) CAD. The mean serum concentration of total BA was twice lower in patients with, versus without CAD (P = 0.005). Adjusted for gender and age, this decrease was an independent predictor of CAD. In a subgroup of 17 patients, statin therapy doubled the serum BA concentration. Decreased serum concentrations of BA were predictors of CAD in humans. A subgroup analysis showed a possible correction by statins. With respect to the anti-atherosclerotic effect of BA in animal models, and their role in human lipid metabolism, this study describe a new metabolic disturbance associated to CAD in human.
- 22 November 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Open AccessCirculating bile acids concentration is predictive of coronary artery disease in human
Synthetized by the liver and metabolized by the gut microbiota, BA are involved in metabolic liver diseases that are associated with cardiovascular disorders. Animal models of atheroma documented a powerful anti-atherosclerotic effect of bile acids (BA). This prospective study examined whether variations in circulating BA are predictive of coronary artery disease (CAD) in human. Consecutive patients undergoing coronary angiography were enrolled. Circulating and fecal BA were measured by high pressure liquid chromatography and tandem mass spectrometry. Of 406 screened patients, 80 were prospectively included and divided in two groups with (n = 45) and without (n = 35) CAD. The mean serum concentration of total BA was twice lower in patients with, versus without CAD (P = 0.005). Adjusted for gender and age, this decrease was an independent predictor of CAD. In a subgroup of 17 patients, statin therapy doubled the serum BA concentration. Decreased serum concentrations of BA were predictors of CAD in humans. A subgroup analysis showed a possible correction by statins. With respect to the anti-atherosclerotic effect of BA in animal models, and their role in human lipid metabolism, this study describe a new metabolic disturbance associated to CAD in human.
- 1 April 2021
- Published by Elsevier in Digestive and Liver Disease
- Vol. 53 (4) , 434-441
Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group
- 1 April 2021
- Published by Elsevier in Digestive and Liver Disease
- Vol. 53 (4) , 434-441
Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group
- Open Access
- 3 March 2020
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 54 (5) , 405-414
Disruption of Circadian Rhythms and Gut Motility
Circadian rhythms ensure that physiological processes occur at the most biologically meaningful time. The circadian timing in the gastrointestinal tract involves interlocking transcriptional and translational feedback loops that culminate in the rhythmic expression and activity of a set of clock genes and related hormones. The suprachiasmatic nucleus and peripheral core molecular clocks oscillate every 24 hours and are responsible for the periodic activity of various segments and transit along the gastrointestinal tract. Environmental cues may alter or reset these rhythms to align them with new circumstances. Colonic motility also follows a circadian rhythm with reduced nocturnal activity. Healthy humans have normal bowel motility during the day, frequently following awakening or following a meal, with minimal activity during the night. Maladjusted circadian rhythms in the bowel have been linked to digestive pathologies, including constipation and irritable bowel syndrome. Our advanced knowledge of the link between the circadian clock and gastrointestinal physiology provides potential therapeutic approaches for the treatment of gastrointestinal diseases. This review seeks to establish evidence for the correlation between circadian rhythm, bowel movements and digestive health, and examine the implications of disrupted circadian rhythms on gut physiology.
- 3 March 2020
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 54 (5) , 405-414
Open AccessDisruption of Circadian Rhythms and Gut Motility
Circadian rhythms ensure that physiological processes occur at the most biologically meaningful time. The circadian timing in the gastrointestinal tract involves interlocking transcriptional and translational feedback loops that culminate in the rhythmic expression and activity of a set of clock genes and related hormones. The suprachiasmatic nucleus and peripheral core molecular clocks oscillate every 24 hours and are responsible for the periodic activity of various segments and transit along the gastrointestinal tract. Environmental cues may alter or reset these rhythms to align them with new circumstances. Colonic motility also follows a circadian rhythm with reduced nocturnal activity. Healthy humans have normal bowel motility during the day, frequently following awakening or following a meal, with minimal activity during the night. Maladjusted circadian rhythms in the bowel have been linked to digestive pathologies, including constipation and irritable bowel syndrome. Our advanced knowledge of the link between the circadian clock and gastrointestinal physiology provides potential therapeutic approaches for the treatment of gastrointestinal diseases. This review seeks to establish evidence for the correlation between circadian rhythm, bowel movements and digestive health, and examine the implications of disrupted circadian rhythms on gut physiology.